This drugmaker is developing breakthroughs like an ‘EpiPen for heart attacks.’ The market has yet to give it credit

The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an “EpiPen for heart attacks.”